
Seres Therapeutics MCRB
$ 7.9
3.13%
Quarterly report 2026-Q1
added 05-05-2026
Seres Therapeutics Current Ratio 2011-2026 | MCRB
Annual Current Ratio Seres Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.889 | 1.03 | 1.59 | 2.04 | 2.18 | 2.2 | 4.9 | 6.51 | 19 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19 | 0.889 | 4.48 |
Quarterly Current Ratio Seres Therapeutics
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.29 | 1.47 | 1.44 | 1.3 | 1.44 | 1.11 | 1.15 | 0.79 | 0.85 | 0.89 | 0.96 | 1.06 | 0.85 | 1.03 | 1.28 | - | 1.34 | 1.59 | 1.8 | 1.6 | 1.89 | 2.04 | 2.04 | 2.04 | 2.04 | 0.73 | 0.73 | 0.73 | 0.73 | 0.71 | 0.71 | 0.71 | 0.71 | 1.47 | 1.47 | 1.47 | 1.47 | 1.95 | 1.95 | 1.95 | 1.95 | 18.9 | 18.9 | 18.9 | 18.9 | 14.7 | 14.7 | 14.7 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.9 | 0.71 | 3.66 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
1.84 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
5.42 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
1.43 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
0.796 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
11.2 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
0.607 | $ 3.14 | 0.16 % | $ 653 M | ||
|
Eton Pharmaceuticals
ETON
|
1.4 | $ 35.13 | 1.97 % | $ 945 M | ||
|
Forte Biosciences
FBRX
|
3.8 | $ 21.7 | 6.84 % | $ 281 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
8.41 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
1.88 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | ||
|
Grifols, S.A.
GRFS
|
1.67 | $ 8.14 | -0.67 % | $ 5.53 B | ||
|
Generation Bio Co.
GBIO
|
1.59 | - | - | $ 344 M | ||
|
IMV
IMV
|
0.826 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
7.95 | $ 91.21 | 0.94 % | $ 22 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.66 | 2.47 % | $ 442 M | ||
|
Ayala Pharmaceuticals
AYLA
|
6.17 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
1.06 | $ 0.87 | 2.78 % | $ 145 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
6.09 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
7.46 | $ 2.61 | -3.7 % | $ 244 M | ||
|
Incyte Corporation
INCY
|
3.89 | $ 97.69 | 0.63 % | $ 19.1 B | ||
|
Anika Therapeutics
ANIK
|
14.4 | $ 15.09 | -0.33 % | $ 216 M | ||
|
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | ||
|
Ionis Pharmaceuticals
IONS
|
1.16 | $ 75.94 | 1.17 % | $ 12.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.4 | 2.41 % | $ 5.6 M | ||
|
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
1.31 | $ 1.6 | 5.61 % | $ 187 M | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
5.43 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 20.88 | 2.0 % | $ 2.66 B | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M |